{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:52:48Z","timestamp":1792194768299,"version":"4.4.0"},"reference-count":24,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCDD"],"abstract":"<jats:p>Background: Percutaneous left-atrial appendage closure (LAAC) is an established method for preventing strokes in patients with atrial fibrillation, offering an alternative to oral anticoagulation. Various occluder devices have been developed to cater to individual anatomical needs and ensure a safe and effective procedure. In this retrospective, monocentric cohort study, we compare different LAAO devices with respect to clinical outcomes, LAA sealing properties, and device-related complications. Methods: We conducted a retrospective analysis of 270 patients who underwent percutaneous LAA closure in our center between 2009 and 2023. Patient data were extracted from medical records, including gender, age at implantation, indication, device type and size, laboratory values, LAA anatomy, periprocedural complications, ECG parameters, transthoracic and transesophageal echocardiography parameters (TTE and TEE), as well as medication at discharge. Moreover, fluoroscopy time and implantation duration, as well as post-implantation clinical events up to 1 year, were collected. Endpoints were bleeding events, recurrent stroke, thrombi on devices, and death. Results: The implanted devices were the Watchman 2.5, Watchman FLX, Amplatzer Cardiac Plug (ACP), and Amulet. The procedural success rate was 95.7% (n = 265), with cactus anatomy posing the most challenges across all devices. The mean patient age was 75.5 \u00b1 7.7 years, with 64.5% being male. The median CHA2DS2-VASc score was 4.8 \u00b1 1.5 and the median HAS-BLED score was 3.8 \u00b1 1.0. Indications for LAA closure included past bleeding events and elevated bleeding risk. Periprocedural complications were most commonly bleeding at the puncture site, particularly after ACP implantation (p = 0.014). Significant peridevice leaks (PDL) were observed in 21.4% of simple sealing mechanism devices versus 0% in double sealing mechanism devices (p = 0.004). Thrombi were detected on devices in six patients, with no subsequent ischemic stroke or thromboembolic event. Comparative analysis revealed no significant differences in the occurrence of stroke, transient ischemic attack (TIA), thromboembolic events, device-related thrombi, or mortality among different device types. A 62.3% relative risk reduction in thromboembolic events and 38.6% in major bleedings could be observed over 568.2 patient years. Conclusions: In summary, our study highlights the efficacy and safety of LAA closure using various occluder devices despite anatomical challenges. Our long-term follow-up findings support LAA closure as a promising option for stroke prevention in selected patient cohorts. Further research is needed to refine patient selection criteria and optimize outcomes in LAA closure procedures.<\/jats:p>","DOI":"10.3390\/jcdd11060158","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T05:40:47Z","timestamp":1716270047000},"page":"158","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparative Assessment of Percutaneous Left-Atrial Appendage Occlusion (LAAO) Devices\u2014A Single Center Cohort Study"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7285-2825","authenticated-orcid":false,"given":"Elham","family":"Kayvanpour","sequence":"first","affiliation":[{"name":"Department of Internal Medicine III, Heidelberg University, 69120 Heidelberg, Germany"},{"name":"DZHK (German Centre for Cardiovascular Research), 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Kothe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Heidelberg University, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3745-0836","authenticated-orcid":false,"given":"Ziya","family":"Kaya","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Heidelberg University, 69120 Heidelberg, Germany"},{"name":"DZHK (German Centre for Cardiovascular Research), 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Pleger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Heidelberg University, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Frey","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Heidelberg University, 69120 Heidelberg, Germany"},{"name":"DZHK (German Centre for Cardiovascular Research), 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Meder","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Heidelberg University, 69120 Heidelberg, Germany"},{"name":"DZHK (German Centre for Cardiovascular Research), 69120 Heidelberg, Germany"},{"name":"Department of Genetics, Stanford Genome Technology Center, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3266-0527","authenticated-orcid":false,"given":"Farbod","family":"Sedaghat-Hamedani","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Heidelberg University, 69120 Heidelberg, Germany"},{"name":"DZHK (German Centre for Cardiovascular Research), 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jjcc.2022.01.004","article-title":"Initial practice of left atrial appendage closure device in Japan; single-center experience","volume":"79","author":"Fukunaga","year":"2022","journal-title":"J. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"E225","DOI":"10.4244\/EIJ-D-19-00128","article-title":"Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: A large transoesophageal echo study","volume":"15","author":"Cresti","year":"2019","journal-title":"EuroIntervention"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/europace\/euz258","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion\u2014An update","volume":"22","author":"Glikson","year":"2020","journal-title":"Europace"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s12265-020-10095-4","article-title":"Design and Rationale of the Swiss-Apero Randomized Clinical Trial: Comparison of Amplatzer Amulet vs Watchman Device in Patients Undergoing Left Atrial Appendage Closure","volume":"14","author":"Galea","year":"2021","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/europace\/euac021","article-title":"Watchman FLX vs. Watchman 2.5 in a Dual-Center Left Atrial Appendage Closure Cohort: The WATCH-DUAL study","volume":"24","author":"Galea","year":"2022","journal-title":"Europace"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.4244\/EIJY15M01_06","article-title":"Left atrial appendage occlusion for stroke prevention in atrial fibrillation: Multicentre experience with the AMPLATZER Cardiac Plug","volume":"11","author":"Tzikas","year":"2016","journal-title":"EuroIntervention"},{"key":"ref_9","first-page":"1","article-title":"3-Year outcomes after left atrial appendage closure in patients with nonvalvular atrial fibrillation: Cardiomyopathy related with increased death and stroke rate","volume":"23","author":"Chen","year":"2023","journal-title":"BMC Cardiovasc. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","article-title":"Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke","volume":"384","author":"Whitlock","year":"2021","journal-title":"New Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jacep.2022.03.001","article-title":"Clinical impact of residual leaks following left atrial appendage occlusion: Insights from the NCDR LAAO registry","volume":"8","author":"Alkhouli","year":"2022","journal-title":"Clin. Electrophysiol."},{"key":"ref_13","first-page":"2127","article-title":"Peridevice leak after transcatheter left atrial appendage occlusion: An analysis of the Amulet IDE trial","volume":"15","author":"Price","year":"2022","journal-title":"Cardiovasc. Interv."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jacc.2022.04.062","article-title":"Impact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure","volume":"80","author":"Dukkipati","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10840-022-01336-4","article-title":"Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device","volume":"66","author":"Korsholm","year":"2023","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4244\/EIJ-D-21-01010","article-title":"Device-related thrombus following left atrial appendage occlusion","volume":"18","author":"Simard","year":"2022","journal-title":"EuroIntervention"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacc.2021.04.098","article-title":"Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion","volume":"78","author":"Simard","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e005997","DOI":"10.1161\/CIRCINTERVENTIONS.117.005997","article-title":"Device Thrombosis After Percutaneous Left Atrial Appendage Occlusion Is Related to Patient and Procedural Characteristics but Not to Duration of Postimplantation Dual Antiplatelet Therapy","volume":"11","author":"Pracon","year":"2018","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.110.976449","article-title":"Safety of percutaneous left atrial appendage closure: Results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry","volume":"123","author":"Reddy","year":"2011","journal-title":"Circulation"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","article-title":"Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation","volume":"71","author":"Fauchier","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"E111","DOI":"10.1002\/ccd.26903","article-title":"Device-associated thrombus formation after left atrial appendage occlusion: A systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet","volume":"90","author":"Lempereur","year":"2017","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","first-page":"1902","article-title":"3-Year Outcomes from the Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE)","volume":"16","author":"Lakkireddy","year":"2023","journal-title":"JACC: Cardiovasc. Interv."},{"key":"ref_24","unstructured":"and Arsanjani, R. (2024). Catheter Management of Left Atrial Appendage Closure Devices, StatPearls."}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/11\/6\/158\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:45:34Z","timestamp":1760107534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/11\/6\/158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":24,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["jcdd11060158"],"URL":"https:\/\/doi.org\/10.3390\/jcdd11060158","relation":{},"ISSN":["2308-3425"],"issn-type":[{"value":"2308-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,21]]}}}